• Nenhum resultado encontrado

Braz. J. Cardiovasc. Surg. vol.25 número1 en v25n1a27

N/A
N/A
Protected

Academic year: 2018

Share "Braz. J. Cardiovasc. Surg. vol.25 número1 en v25n1a27"

Copied!
1
0
0

Texto

(1)

126

Rev Bras Cir Cardiovasc 2010; 25(1): 126

NEWS

Dr. Paulo Pêgo-Fernandes presents an unpublished

study at the Congress of STS

Dr. Paulo Pêgo-Fernandes, professor of FMUSP (INCOR), Editor of the São Paulo Medical Journal, and member of the Editorial Board of the Brazilian Journal of Cardiovascular Surgery (BJCVS), was featured in an article in the Bulletin of the 46th Annual Meeting of the Society of Thoracic Surgeons (STS), held from 24 to 27 January in Fort Lauderdale, Florida, United States.

The article approaches the presentation of Phase I of a trial on “Therapeutic endoscopic thoracic sympathectomy” by Dr. Paulo Pêgo. 15 patients with dilated cardiomyopathy and an ejection fraction below 40% participated in the trial, all in functional class II or III according New York Heart Association, with heart rate above 65 beats per minute, despite the correct use of beta-blockers, or because of intolerance of the patient to the drug.

The procedure proved to be safe and no patients experienced adverse events related to the procedure in the perioperative period or during the initial 6 months of follow-up. According to Dr. Paulo Pêgo, the technique is easy to apply and shows to be safe in patients with severe heart failure, and could be an alternative to achieve sympathetic blockade in patients with severe dilated cardiomyopathy.

Referências

Documentos relacionados

negative); Lanes 1, 2 and 4 (isolates CAMP test positive); Lane 5 reference strain Rhodococcus equi ATCC 6939; M = DNA size marker (100 bp).. five isolates CAMP test-positive

Objectives: This study aimed to identify CA-MRSA infections both phenotypically and geno- typically, to determine their spectrum of antibiotic resistance, and to establish the

The rate of resistance to antibiotics of Acinetobacter baumannii and Pseudomonas aeruginosa strains isolated from patients with MVAP was higher than those isolated from

This review focuses on a brief discussion about opportunistic infections still present in late diagnosed HIV-infected patients and describes new forms of HIV-related

xylosoxidans at our neonatal intensive care unit, beginning with the index case detected at November 2009 until cessation of the outbreak in April 2010, were evaluated

Our study lived up to our assumption to sug- gest that, the HCV core antigen based ELISA can be used for screening patients presenting with signs and symptoms of acute hepatitis, or

In the second phase of this study, pregnant women were prospectively followed to eval- uate postpartum effects of this infection as well as upon their neonates up to sixty (60)

Results: DNA sequencing revealed that 68.9% of multidrug-resistant strains have point muta- tions at codon 315 of the katG gene, 19.8% within the mabA-inhA promoter, and 98.0% at